KELI Therapeutics
offers cells from placenta (mesenchymal stem cells, epithelial cells, trophoblast and NK-cells), Umbilical cord (mesenchymal stem cells) and from cartliage (healthy & osteoarthritis chondrocytes) in R&D quality as well as in GMP quality. Besides cells and concerning media they also offer exosomes derived from the mentioned cells.
Besides the standrad products KELI Therapeutics is flexible to customizations (e.g. cell isolation using FBS or hPL; expansion in 2D or 3D, number of cells/vial and more).
Chorionic plate Mesenchymal Stem Cells - (Keli Therapeutics)
Cells
Decidua NK-Cells (CD56+CD3-) - (Keli Therapeutics)
Cells
Human healthy articular chondrocytes (CH-H) - (Keli Therapeutics)
Cells
Human Osteoarthritic chondrocytes (CH-OA) - (Keli Therapeutics)
Cells
Placental Amniotic epithelial cells - (Keli Therapeutics)
Cells
Placental Amniotic Mesenchymal Stem Cells - (Keli Therapeutics)
Cells
Placental Chorionic villi Mesenchymal Stem Cell derived Exosomes - (Keli Therapeutics)
Exosomes
Placental Chorionic villi Mesenchymal Stem Cells - (Keli Therapeutics)
Cells
Placental Chorionic villous trophoblast cells - (Keli Therapeutics)
Cells
Placental Decidua basalis Mesenchymal Stem Cells - (Keli Therapeutics)
Cells
Umbilical cord blood Mesenchymal Stem Cells (UC-MSCs) - (Keli Therapeutics)
Cells
Umbilical cord tissue Mesenchymal Stem Cells (UCT-MSCs) - (Keli Therapeutics)
Cells
